Metoprololtartraat Sandoz

Metoprolol tartrate, the active ingredient in Metoprololtartraat Sandoz, is a beta blocker presented as a tablet for oral use. It is used to manage hypertension, angina pectoris, heart failure and certain cardiac arrhythmias in adult patients. It is indicated for patients requiring cardiovascular risk reduction and symptom control.

GNH USA supplies Metoprololtartraat Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable supply chains across Europe, Asia and the Americas.

Metoprolol tartrate is a selective β1‑adrenergic blocker used in cardiovascular disease management. - Hypertension: lowers blood pressure by reducing heart rate and cardiac output. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Heart failure: improves survival and reduces hospitalizations by decreasing cardiac workload. - Cardiac arrhythmias: controls heart rate and stabilizes rhythm in supraventricular tachycardia.

Metoprolol tartrate may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Fatigue - Dizziness - Cold extremities - Bradycardia - Gastrointestinal discomfort

Serious or Rare Side Effects: - Severe bradycardia or heart block - Hypotension unresponsive to treatment - Bronchospasm in patients with asthma - Depression or mood changes

When prescribing Metoprolol tartrate, clinicians should consider several safety measures. - Initiate therapy cautiously: start at low dose in patients with severe cardiac disease. - Monitor heart rate: avoid use if resting heart rate is below 50 bpm without supervision. - Assess renal and hepatic function: dose adjustments may be needed in impairment. - Avoid abrupt discontinuation: taper gradually to prevent rebound hypertension or tachycardia. - Contraindications: do not use in patients with overt heart block, cardiogenic shock, or severe asthma. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and light.

Metoprolol tartrate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Combined use with non‑selective β‑blockers or calcium channel blockers (verapamil/diltiazem): risk of profound bradycardia and AV block. - Concomitant administration with potent CYP2D6 inhibitors (e.g., quinidine, paroxetine): may markedly increase metoprolol plasma levels.

Moderate Interactions (Monitor Closely): - Concurrent use with antidiabetic agents: β‑blockade can mask hypoglycemia symptoms, requiring glucose monitoring. - Interaction with NSAIDs or selective COX‑2 inhibitors: may attenuate antihypertensive effect. - Use with inhaled β2‑agonists: may reduce bronchodilator response, monitor respiratory status.